YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Clinical trial NCT05448820 · UNKNOWN
Trial details
- NCT number
- NCT05448820
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2023-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.